Fmoc-Ala-Gly-OH is an Fmoc-protected amino acid dipeptide acid consisting of alanine and glycine connected through an amide bond, with a terminal carboxylic acid (-COOH) at the C-terminus and a free amino acid residue incorporated into the peptide backbone. The N-terminus is masked by an Fmoc (9-fluorenylmethoxycarbonyl) protecting group, which controls chemoselectivity during stepwise coupling, while the alanine side chain bears a methyl substituent and the glycine side chain is hydrogen, giving the molecule a defined aliphatic character and two backbone carbonyls. Fmoc-Ala-Gly-OH is used as a peptide synthesis intermediate in solid-phase or solution-phase strategies to assemble defined peptide fragments and to provide a protected N-terminus for sequential elongation.
CAT No: CP26219
CAS No:116747-54-7
Synonyms/Alias:(S)-2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanamido)acetic acid;116747-54-7;FMOC-L-ALANYL-GLYCINE;CTK7J5178;MolPort-023-223-400;ZINC2556578;AKOS025405022;AK175093;Fmoc-Ala-Gly-OH;2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoyl]amino]acetic acid;Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanyl-;(((9H-Fluoren-9-yl)methoxy)carbonyl)-L-alanylglycine;N-[N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-alanyl]-glycine;MFCD00190870;Fmoc-L-Ala-Gly-OH;SCHEMBL23882989;GOCNEQGFDAXBQE-LBPRGKRZSA-N;(S)-2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanamido)acetic acid;AKOS025405022;AS-79995;CS-0452330;F75619;EN300-1513549;(S)-2-(2-(((9H-fluoren-9-yl)methoxy)carbonylamino)propanamido)acetic acid;[(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}PROPANAMIDO]ACETIC ACID;2-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]acetic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-alaninyl-glycine (Fmoc-L-Ala-Gly-OH)
Fmoc-Ala-Gly-OH is a protected dipeptide acid featuring an Fmoc-protected N-terminus and a free C-terminal carboxylic acid, with an Ala-Gly sequence that encodes a defined stereochemical context at the alanine residue. The structure combines an aromatic fluorenylmethoxycarbonyl group for orthogonal N-protection with peptide-compatible amide linkages and a terminal carboxyl group that can be activated for coupling or converted into protected derivatives. The presence of a secondary amide backbone and the glycine residue supports conformational flexibility during peptide assembly while maintaining a predictable reactivity profile under standard peptide synthesis conditions. The compound functions as a stable, isolable peptide building block and chiral synthesis intermediate precursor for downstream peptide construction, fragment elaboration, and analytical reference material preparation.
1. Peptide Synthesis
Fmoc-Ala-Gly-OH serves as a direct peptide building block for solid-phase peptide synthesis and fragment-based chain assembly, where the Fmoc group enables controlled N-deprotection and subsequent coupling at the N-terminus. The Ala-Gly amide backbone provides a ready-made dipeptide motif, while the free C-terminal carboxylic acid supports activation to form peptide bonds with incoming amino acid building blocks. The stereogenic center at alanine is preserved through the sequence, supporting stereochemically defined peptide analogs and minimizing ambiguity in structure determination. The resulting dipeptide incorporation supports the generation of longer peptides, peptidomimetics, and sequence-defined research materials used in biochemical and materials-oriented studies.
2. Protected Amino Acid Chemistry
Fmoc-Ala-Gly-OH can be employed in protected amino acid derivative workflows where orthogonal protection and stepwise functional group exposure are required for controlled synthesis. The Fmoc-protected N-terminus provides a removable protecting group strategy compatible with peptide coupling cycles, while the terminal carboxylic acid remains available for derivatization into activated esters, amides, or other downstream intermediates. The Ala-Gly sequence reduces the need for separate residue installation, streamlining protected amino acid synthesis routes that rely on peptide bond formation as the key transformation. The compound can therefore function as a biochemical research intermediate for producing C-terminally modified dipeptide fragments and for preparing standardized inputs for peptide chemistry libraries.
3. Bioconjugation Chemistry
Fmoc-Ala-Gly-OH is suitable for bioconjugation and chemical biology workflows that require a defined peptide handle for attachment to biomolecules or surfaces. The free C-terminal carboxyl group can be converted into reactive coupling forms for amide bond formation or for linking strategies that preserve the peptide backbone integrity. The Fmoc group can be used to maintain N-terminal protection during intermediate handling, enabling cleaner downstream conjugation steps once deprotection or functional activation is performed. The Ala-Gly motif contributes a compact, flexible linker segment that can be incorporated into conjugates for biomolecule labeling, affinity reagent construction, and controlled presentation of peptide epitopes.
4. Analytical Research Standards
Fmoc-Ala-Gly-OH can be used to prepare analytical standards and reference fragments for peptide characterization by LC-MS, HPLC, and MS/MS method development. The Fmoc chromophore provides strong UV detectability, supporting trace-level monitoring of peptide intermediates and aiding in the verification of coupling and deprotection steps during peptide synthesis optimization. The defined dipeptide sequence and preserved stereochemistry at the alanine residue enable unambiguous identification of the fragment in complex mixtures. The compound can also serve as a calibration or structural reference for quantifying peptide building block incorporation and for validating analytical workflows used in peptide science and synthetic organic chemistry.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-Ala-Gly-OH is applicable to pharmaceutical manufacturing and process chemistry contexts as a controlled peptide fragment intermediate used in the preparation of sequence-defined peptide materials. The combination of Fmoc N-protection and a free C-terminal carboxylic acid aligns with scalable peptide coupling logic, supporting reproducible intermediate generation for downstream assembly. The compact dipeptide structure can reduce synthetic steps when a specific Ala-Gly motif is required in a larger active or functional peptide sequence, including peptidic linkers and excipient-like peptide components. The compound's peptide-compatible functional groups enable integration into industrial fine chemical synthesis strategies focused on robust intermediate handling and downstream conversion to protected or activated derivatives.
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.